What is PsyBio Therapeutics Corp. (PSYB.V)?

PsyBio Therapeutics Corp. (PSYB.V) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

PsyBio Therapeutics Corp. (PSYB.V)

Stock analysis · TSXV · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.66

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

PsyBio Therapeutics Corp. (PSYB.V) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 29, 2022

EPS $-0.01 vs est. $-0.01

Missed by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About PsyBio Therapeutics Corp.

Based in Coconut Creek, Florida, PsyBio Therapeutics Corp. operates as a biotechnology enterprise dedicated to the development, evaluation, and market launch of regulated pharmaceuticals rooted in psychedelic compounds. Its primary objective is to address various mental health issues and other ailments across the United States.